MedAvail Postpones Reporting of First Quarter 2023 Financial Results
16 May 2023 - 6:01AM
MedAvail Holdings, Inc. (NASDAQ: MDVL) (“MedAvail” or the
“Company”), an innovative pharmacy technology company, announced
today that it is postponing its scheduled earnings release and
conference call for the quarter ended March 31, 2023 previously
scheduled for today.
The Company requires additional time to complete
the preparation of its condensed consolidated financial statements
as of and for the quarter ended March 31, 2023. The Company will
file a timely Notification of Late Filing on Form 12b-25 to extend
the filing deadline for the Company’s Quarterly Report on Form 10-Q
for the quarter ended March 31, 2023.
The Company will announce the date and time of
its scheduled first quarter ended March 31, 2023 financial results
and conference call in a future press release.
About MedAvail
MedAvail Holdings, Inc. (NASDAQ: MDVL) is a
technology-enabled pharmacy company, providing turnkey in-clinic
pharmacy services through its proprietary robotic dispensing
platform, the MedAvail MedCenter, to Medicare clinics, urgent care
clinics, large healthcare systems, mass merchandise retailers,
hospital systems and other healthcare channels. MedAvail helps
patients to optimize drug adherence, resulting in better health
outcomes. Learn more at www.medavail.com.
Contacts:
Investor RelationsInvestor RelationsSteven
Halper/Caroline PaulManaging Directors, LifeSci
Advisorsir@medavail.com
SOURCE MedAvail Holdings, Inc.
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jun 2024 to Jul 2024
MedAvail (NASDAQ:MDVL)
Historical Stock Chart
From Jul 2023 to Jul 2024